Articles Tagged With:
-
Quadriplegics’ Hand and Arm Movements Restored
In 2012, Michael D. Bavlsik, MD, his son, and other Boy Scouts were traveling in Minnesota when his van collided with a boat and a trailer. The accident left Bavlsik a quadriplegic. The primary care physician and father of eight is now able to feed himself, write, examine patients’ ears, and drive, based on a newly reported surgical technique. -
Evaluation of Syncope in the Emergency Department
This issue of Emergency Medicine Reports covers the current landscape of syncope from the ED perspective and continues to stress the importance of physician judgment.
-
One Year Later, Ebola Lessons Emerge
New report highlights problems, offers recommendations for future improvements for epicenter of last year’s infectious disease crisis.
-
Man-made Disaster: In-hospital Management
Man-made disaster directly impacts the emergency department and hospital when a mass casualty situation ensues, and is the focus of this review article. Using contemporary examples and the current literature, what follows is a primer on the causes, injury patterns, resource utilization, triage, and preparation for man-made mass casualty events.
-
Interdisciplinary mistrust, communication breakdowns cited in survey of ED handoffs
Emergency physicians point to duplicate orders, other problems related to unclear timing on transfer of care.
-
Travel history key to picking up on signs of bubonic plague
Health officials caution that symptoms of plague can mimic other types of infections.
-
Poor Planning, Communication Hindered Ebola Patient Care
A panel doles out the blame for misunderstood roles and inadequate drills.
-
ECG Review: A 43-Year-Old Man with Atypical Chest Pain
-
Clinical Briefs
In this section: reversing the anticoagulant effect of dabigatran; considering the likelihood of occult cancer causing unprovoked deep venous thrombosis; and cardiovascular autonomic neuropathy occurs earlier in type 2 diabetes.
-
Evolocumab Injection (Repatha)
Evolocumab is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in patients who require additional lowering of LDL-C.